MarketCapTrends
URGN
Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare

Urogen Pharma Ltd. Total Liabilities 2016–2025

Urogen Pharma Ltd. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Urogen Pharma Ltd. total liabilities for the quarter ending December 31, 2025 were 305.9M, a 3.88% increase year-over-year.
  • Urogen Pharma Ltd. total liabilities for 2025 were 305.9M, a 3.88% increase from 2024.
  • Urogen Pharma Ltd. total liabilities for 2024 were 294.5M, a 20.94% increase from 2023.
  • Urogen Pharma Ltd. total liabilities for 2023 were 243.5M, a 8.24% increase from 2022.
  • Urogen Pharma Ltd. total liabilities for 2022 were 225.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Urogen Pharma Ltd. Annual Total Liabilities (Millions of US $)
2025$306
2024$295
2023$244
2022$225
2021$111
2020$26
2019$22
2018$13
2017$7
Urogen Pharma Ltd. Quarterly Total Liabilities (Millions of US $)
2025-12-31$306
2024-12-31$295
2023-12-31$244
2022-12-31$225
2021-12-31$111
2020-12-31$26
2019-12-31$22
2018-12-31$13
2017-12-31$7

Urogen Pharma Ltd. Total Liabilities — FAQ

Urogen Pharma Ltd. (URGN) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see URGN's total liabilities history?

The chart and table above show Urogen Pharma Ltd.'s total liabilities by year and by quarter, including the growth rate.